A new study reveals the role circular RNA plays in brain function, including synaptic transmission and sensorimotor gating.
Using gene editing to disrupt a gene in the thalamus that codes for a protein that binds to GABA boosted the activity of delta waves and promoted deep sleep in mouse models.
Using CRISPR gene editing technology, researchers target the Shank3 gene in monkey embryos. Research backs previous findings of the importance of the Shank3 gene for brain development and its role in autism.
Researchers successfully use CRISPR-Cpf1 to correct Duchenne muscular dystrophy in both animal and human cells.
Researchers have successfully reduced some symptoms associated with fragile X syndrome in mice with the help of CRISPR-Cas 9 gene editing.
Using CRISPR, researchers have identified a new set of genes that may be implicated in both ALS and frontotemporal dementia.
Researchers use CRISPR gene editing technology to target GABA receptors in order to help treat mood disorders.
CRISPR technology allows researchers to illuminate and monitor alpha synuclein in the brain.
A groundbreaking Nature study reports researchers have used CRISPR gene editing technology to correct a mutation that causes hypertrophic cardiomyopathy in embryos. The technique also prevents the mutation from passing to future generations.
Researchers re-purposed CRISPR gene editing technology to study genes targeted by particular antibiotics. The study sheds light on how pharmacologists can improve existing antibiotics and develop new ones.
New application of DNA editing technique, CRISPR-Cas9, may open the door the new treatments for cancer and autism.
Researchers have developed a new protein that can alter DNA in living cells with much higher precision than current methods.
